Cannabis Dosing and Tolerability in AIMSS Treatment
Clinical Takeaway Topical cannabis balms were well tolerated in women with aromatase inhibitor-related joint and bone pain, addressing a common side effect that affects treatment adherence in breast cancer patients. This feasibility trial provides…
Topical Cannabis for AIMSS: Clinical Trial Evidence
Clinical Takeaway Topical cannabis balms were tolerable and feasible for women with aromatase inhibitor-related joint pain and stiffness, which affects about two-thirds of women taking these breast cancer medications. This approach could help improve…
Topical Cannabis for AIMSS: Medical Cannabis Evidence-Based Care
Clinical Takeaway Topical cannabis balms were tested in a randomized open-label trial to evaluate their safety and feasibility for managing joint pain and stiffness caused by aromatase inhibitor therapy in breast cancer patients. The study found the…
Pharmacological Insights into Cannabidiol for Wound Healing and Bone Regeneration | ACS Omega
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdWound HealingOrthopedicsTopical…
A Randomized, Open-Label Trial to Assess Feasibility and Tolerability of Topical Cannabis Balms for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS).
Aromatase inhibitors (AIs) are commonly used for postmenopausal women with hormone receptor-positive breast cancer. Nearly two-thirds of women on AIs have ar...
Topical Cannabis for AIMSS: Medical Cannabis Evidence
Clinical Takeaway In this randomized trial, topical cannabis balms were evaluated for feasibility and tolerability in postmenopausal breast cancer patients experiencing joint pain and stiffness from aromatase inhibitor therapy. The study found that…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trial
Clinical Takeaway This small randomized trial tested whether topical cannabis balms were feasible and tolerable for managing joint pain and stiffness caused by aromatase inhibitors in postmenopausal breast cancer patients. The study found that topical…
Topical Cannabis Balms for AIMSS: Clinical Trial Data
Clinical Takeaway Topical cannabis balms were tested in a randomized, open-label trial among postmenopausal women with hormone receptor-positive breast cancer who developed musculoskeletal pain and joint stiffness from aromatase inhibitor therapy. The…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
Clinical Takeaway Topical cannabis balms were tested in a randomized trial for postmenopausal breast cancer patients experiencing joint pain and stiffness caused by aromatase inhibitor therapy. The study evaluated whether this approach was practical and…